Tafluprost Ophthalmic Solution/ Drops
Product Images NDC 66993-429

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tafluprost Ophthalmic (NDC 66993-429). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Tafluprost Ophthalmic Solution 1)

Chemical structure of tafluprost, the active ingredient in Tafluprost Ophthalmic solution. The diagram shows the molecular arrangement including hydroxyl groups, fluorine atoms, an ester group, and a phenyl ring.*

FDA Label Image

Figure A (Tafluprost Ophthalmic Solution 2)

An instructional illustration showing a hand holding an ophthalmic dropper bottle upside down, with a drop being dispensed from the nozzle. This image typically represents the usage or administration method for ophthalmic solution drops like Tafluprost Ophthalmic, 0.0045 mg/0.3 mL.*

FDA Label Image

Figure B (Tafluprost Ophthalmic Solution 3)

An instructional black-and-white illustration showing a person properly opening or preparing an ophthalmic vial or container. The image depicts two hands: one holding the vial upright and the other twisting or removing the cap to access the solution inside.*

FDA Label Image

Figure C (Tafluprost Ophthalmic Solution 4)

An instructional illustration showing a person applying ophthalmic solution drops to the eye. The person tilts their head back and uses one hand to hold the eye open while the other hand positions the dropper above the eye.*

FDA Label Image

Figure D (Tafluprost Ophthalmic Solution 5)

Illustration showing the administration of ophthalmic solution drops to a person's eye. A hand is gently pulling down the lower eyelid of the eye, while another hand is positioned above, dispensing a drop of solution into the eye. This diagram visually demonstrates the process of applying eye drops.*

FDA Label Image

Label (Tafluprost Ophthalmic Solution 6)

Label for Tafluprost Ophthalmic Solution 0.0015%, indicating it is Rx only and manufactured for Prasco Laboratories. The text is displayed in a rectangular box with a blue and pink border.*

FDA Label Image

Pouch (Tafluprost Ophthalmic Solution 7)

Label for Tafluprost Ophthalmic Solution 0.0015%, a sterile ophthalmic solution in single-use containers. Each container holds 0.3 mL, with the active ingredient tafluprost at 0.0015% concentration (4.5 mcg per container). Manufactured for Prasco Laboratories, this product is preservative-free and requires refrigeration. The label includes storage instructions, usage directions, and is marked Rx only.*

FDA Label Image

Carton (Tafluprost Ophthalmic Solution 8)

Packaging label for Tafluprost Ophthalmic Solution 0.0015% by Prasco Laboratories. The label indicates the product is a sterile, preservative-free topical eye solution supplied in single-use containers. It includes storage instructions to refrigerate and details the active ingredient concentration as 0.0015% tafluprost per 0.3 mL container, with a total of 30 single-use containers per package.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.